All data are based on the daily closing price as of June 27, 2025
n

Nippon Shinyaku

4516.TSE
21.59 USD
-0.08
-0.37%

Overview

Last close
21.59 usd
Market cap
1.45B usd
52 week high
34.87 usd
52 week low
17.41 usd
Target price
29.6 usd

Valuation

P/E
6.4516
Forward P/E
12.9199
Price/Sales
1.3111
Price/Book Value
0.8505
Enterprise Value
1.07B usd
EV/Revenue
0.9631
EV/EBITDA
3.6487

Key financials

Revenue TTM
1.11B usd
Gross Profit TTM
754.29M usd
EBITDA TTM
286.65M usd
Earnings per Share
3.34 usd
Dividend
0.86 usd
Total assets
1.90B usd
Net debt
-352.26M usd

About

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
  • Symbol
    4516.TSE
  • Exchange
    TSE
  • Isin
    JP3717600005
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Kyoto
  • Web site
    https://www.nippon-shinyaku.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top